BioCorRx (BICX) Total Debt (2013 - 2026)

BioCorRx has disclosed Total Debt across 12 years of filings, most recently posting $69155.0 for Q1 2026.

• Total Debt for Q1 2026 came in at $69155.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $69155.0 (changed N/A YoY), and the FY2025 annual result was $69537.0, down 2.1% from the prior year.
• Total Debt came in at $69155.0 for Q1 2026 at BioCorRx, down from $69537.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $3.1 million in Q2 2022 to a low of $69155.0 in Q1 2026.
• The 5-year median for Total Debt is $80190.0 (2024), against an average of $872541.5.
• Across the five-year window, Total Debt soared 1252.86% in 2023 and sank 94.25% in 2025, its largest moves.
• BioCorRx's Total Debt stood at $73850.0 in 2022, then jumped by 1252.86% to $999088.0 in 2023, then sank by 92.89% to $71029.0 in 2024, then declined by 2.1% to $69537.0 in 2025, then dropped by 0.55% to $69155.0 in 2026.
• The last three Total Debt figures came in at $69155.0 (Q1 2026), $69537.0 (Q4 2025), and $69803.0 (Q3 2025), per Business Quant data.